AB0351 Differential perception about the csdmards on drug-induced interstitial lung disease between rheumatologists and non-rheumatologists

Background

As disease modified anti-rheumatic-drugs (DMARDs) were the mainstay in the treatment of rheumatoid arthritis (RA), the opportunity for general physicians to also prescribe DMARDs has recently increased in Japan. After DMARDs were initiated by specialists, subsequent drug prescription by general physicians during remission should be expected¹. However, general physicians are more likely than rheumatologists to feel...